Deciphering the oncogenic influence of Pasteurella multocida: Implications of matrix metalloproteinase activation

Jyotsna Nambiar1, Meera Venugopal1, Sanu Korumadathil Shaji2

  • 1Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P O, Kollam, Kerala, 690525, India.

Heliyon
|March 3, 2025
PubMed

Insights

Pathogenic bacteria like Pasteurella multocida promote cancer cell proliferation by interfering with host cell signaling. This study shows bacterial components induce matrix metalloproteinases and survival pathways, increasing cancer cell migration and invasion.

Area of Science:

  • Microbiology and Cancer Biology
  • Investigates the intricate interplay between bacterial pathogens and host cellular mechanisms in cancer progression.

Background:

  • Pathogenic bacteria, such as Pasteurella multocida, can exploit host cells by disrupting signaling pathways.
  • Pasteurella multocida toxin (PMT) is a potent mitogen with tumor-promoting properties, highlighting the bacterium's potential role in cancer.
  • Understanding how bacteria influence cancer cell behavior is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To examine the mitogenic potential of Pasteurella multocida components on fibrosarcoma cells (HT1080).
  • To investigate the effects of P. multocida on matrix metalloproteinase (MMP) activity, cell survival pathways, and cancer cell migration/invasion.
  • To evaluate the impact of P. multocida on plumbagin-induced cell death in cancer cells.

Main Methods:

  • Assessed the mitogenic effects of P. multocida cell lysate and culture supernatant on HT1080 fibrosarcoma cells.
  • Measured Matrix metalloproteinase-2 (MMP-2) and Matrix metalloproteinase-9 (MMP-9) activity, along with Tissue Inhibitor of Metalloproteinases (TIMP-2) and reversion inducing cysteine rich protein with kazal motifs (RECK) levels.
  • Analyzed the activation of p44/42MAPK and Akt signaling pathways and evaluated cell migration and invasion assays.
  • Investigated the influence of P. multocida components on plumbagin-induced cell death.

Main Results:

  • P. multocida cell lysate and supernatant significantly induced MMP-2 and MMP-9 activity.
  • Downregulation of endogenous MMP inhibitors (TIMP-2 and RECK) was observed.
  • Mitogenic and cell survival pathways (p44/42MAPK, Akt) were induced, leading to increased HT1080 cell migration and invasion.
  • Bacterial components reduced plumbagin-induced cancer cell death, indicating a pro-proliferative effect.

Conclusions:

  • Pasteurella multocida components promote cancer cell proliferation by enhancing MMP activity and survival pathways.
  • Bacterial infections can worsen existing cancers by increasing cell migration, invasion, and resistance to cell death.
  • Novel therapeutic approaches are needed to address the role of bacterial infections in cancer progression.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K